ARHGAP11A, a member of Rho GTPase activating protein family, as a prognostic biomarker linked to DNA damage response across pan-cancer
ARHGAP11A is a promising prognostic marker in cancer, with potential therapeutic implications through targeting DNA repair pathways and modulating the tumor immune microenvironment.
Authors
- Yuqiong Ding (ORCID: https://orcid.org/0000-0002-8588-484X)
- Ke Tan (ORCID: https://orcid.org/0000-0001-5151-8158)
- Zhen Yan (ORCID: https://orcid.org/0000-0002-4826-9813)
- Jiaqi Zhang (ORCID: https://orcid.org/0000-0002-4656-1909)
- Liyuan Zhang (ORCID: https://orcid.org/0000-0002-7469-1743)
- Cheng Chen (ORCID: https://orcid.org/0000-0002-9583-7991)
- Yun Wu (ORCID: https://orcid.org/0000-0002-4071-8151)
- Xuetong Wang (ORCID: https://orcid.org/0009-0002-2378-8585)
Institutions
- Washington University in St. Louis (US)
- Soochow University (CN)
- Second Affiliated Hospital of Soochow University (CN)
- Hangzhou Cancer Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1186/s12885-025-15106-8
- Primary Topic
- Cancer-related Molecular Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- China Postdoctoral Science Foundation
- Nanjing Medical University
- Soochow University